TASCENSO ODT FDA approval date
The FDA approved TASCENSO ODT on 23 Dec 2021.
- FDA approval date
- 23 Dec 2021
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as FINGOLIMOD LAURYL SULFATE
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2021-12-23Day | TASCENSO ODT | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA214962", "applicant_as_listed_by_fda": "CYCLE", "brand_names": ["TASCENSO ODT"], "active_ingredients": ["FINGOLIMOD LAURYL SULFATE"], "submission_type": "ORIG", "submission_number": "2", "submission_status": "AP", "submission_status_date": "20211223", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |